RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) announced today that the exchange of Preferred Shares for Common Shares has been completed. Jim Holmes, CEO of Lifeline Biotechnologies, stated, “The exchange of Preferred Shares for Common shares has been completed as a part of the capital restructuring of the Company. We anticipate that the exchange could provide the participating shareholders an opportunity to benefit from the impending reverse split of the remaining common shares, which is being considered by the Board of Directors.”
